Norway Vaccine Market Size & Outlook, 2026-2033

Name: Norway Vaccine Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The vaccine market in Norway is expected to reach a projected revenue of US$ 787.2 million by 2033. A compound annual growth rate of 5.2% is expected of Norway vaccine market from 2026 to 2033.

Pharmaceuticals
- Vaccines
  - Vaccine Market Outlook

Norway vaccine indication outlook (Revenue, USD million, 2021-2033)
- Viral Vaccines
  - Hepatitis
    - Pediatric (Children) Hepatitis
    - Adult Hepatitis
  - Influenza
    - Pediatric (Children) Influenza
    - Adult Influenza
  - HPV
    - Pediatric (Children) HPV
    - Adult HPV
  - MMR
    - Pediatric (Children) MMR
    - Adult MMR
  - Rotavirus
    - Pediatric (Children) Rotavirus
    - Adult Rotavirus
  - Herpes Zoster
    - Pediatric (Children) Herpes Zoster
    - Adult Herpes Zoster
  - Japanese Encephalitis
    - Pediatric (Children) Japanese Encephalitis
    - Adult Japanese Encephalitis
  - RSV
    - Pediatric (Children) RSV
    - Adult RSV
  - Others Viral Vaccines
    - Pediatric (Children) Others Viral Vaccines
    - Adult Others Viral Vaccines
- Bacterial Vaccines
  - Meningococcal Diseases
    - Pediatric (Children) Meningococcal Diseases
    - Adult Meningococcal Diseases
  - Pneumococcal diseases
    - Pediatric (Children) Pneumococcal diseases
    - Adult Pneumococcal diseases
  - DPT
    - Pediatric (Children) DPT
    - Adult DPT
  - Others Bacterial Vaccines
    - Pediatric (Children) Others Bacterial Vaccines
    - Adult Others Bacterial Vaccines
- Cancer Vaccines
  - Pediatric (Children) Cancer Vaccines
  - Adult Cancer Vaccines
- Allergy Vaccines
  - Pediatric (Children) Allergy Vaccines
  - Adult Allergy Vaccines
- Other Indication
  - Pediatric (Children) Other Indication
  - Adult Other Indication
Norway vaccine type outlook (Revenue, USD million, 2021-2033)
- Subunit Vaccines
  - Recombinant Vaccines
  - Conjugate Vaccines
  - Toxoid Vaccines
- Inactivated
- Live Attenuated
- mRNA Vaccines
- Viral Vector Vaccines
Norway vaccine route of administration outlook (Revenue, USD million, 2021-2033)
- Oral
- Parenteral
- Nasal
Norway vaccine age group outlook (Revenue, USD million, 2021-2033)
- Pediatric Age Group
- Adult Age Group
Norway vaccine distribution channel outlook (Revenue, USD million, 2021-2033)
- Hospital & Retail Pharmacies
- Government Suppliers
- Others Distribution Channel

Norway Vaccine Market Size & Outlook, 2026-2033

Data Tree

Sign up - it's easy, and free!